Technicals for Zydus Lifesciences Limited

Price Summary

On 2026-07-01, Zydus Lifesciences Limited's stock began at 1112.9, peaked at 1125.9, bottomed at 1105.5, and closed -0.33% down at 1109.2, with a volume of 1005272 shares.
Throughout the 52-week period, the stock hit a high of 1121.3 and a low of 860.6.

Technicals

Support and Resistance: At 1109.2, the price is supported by 1099.3 and resisted by 1099.3. This indicates that the price for Zydus Lifesciences Limited might fluctuate between these levels, with 1099.3 acting as a support and 1099.3 limiting further upward movement.


Aroon: The current reading of the AROON indicator suggests a neutral stance, with no clear signals indicating an upward or downward direction. This lack of directional bias suggests the market may be in a period of consolidation or uncertainty.


Bol. Bands: The BOLL BANDS is in a neutral stance, not pointing to a clear trend in either direction. This suggests that the market may be lacking strong momentum, making it difficult to predict the next move.


Parabolic SAR: The PSAR continues to indicate a bullish outlook, setting a crucial support level. This strong support could bolster the ongoing upward trend, suggesting that the market may remain in a positive trajectory. Investors may view this as a sign of sustained bullish momentum.


Stochastic: The stochastic indicator reflects bullish conditions for ZYDUSLIFE, with the K-line above both the D-line and the 80 level. This setup suggests strong upward momentum, implying that the market may continue to experience gains. Investors could interpret this as a sign of ongoing strength.


Tripple Moving Agerage: The alignment of the 20, 50, and 100 moving averages suggests a bearish trend, but the wavering slopes of the 20 and 50 SMAs hint at a potential shift. This weakening of momentum could indicate that the bearish trend is running out of steam, possibly leading to a bullish reversal in the near future. Investors should be aware of the possibility of a market turnaround as the current downtrend weakens for Zydus Lifesciences Limited.


When evaluating a company's technical data, such as stock price charts or volume, it is essential to first consider its fundamentals. These fundamentals include financial stability, growth potential, and competitive advantages. Additionally, understanding the broader industry in which the company operates offers context that helps to make sense of technical patterns. By examining both the company's internal strengths and external environment, one can make more accurate and meaningful conclusions about its stock performance.